Skip to contentP
Precision Biosciences Inc
P
DTILPrecision Biosciences Inc Q1 2025 · 10-Q
Revenue$29.00K$29.00K−99.8% vs Q1 2024 Net Income-$20.57M-$20.57MN/M vs Q1 2024 EPS Diluted-$2.21-$2.21N/M vs Q1 2024 Operating Income-$22,112,000N/M Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Precision Biosciences Inc · CIK 1357874 · Engraved from SEC EDGAR
Free Cash Flowderived-$19,116,000N/M Margins · derivedOperating margin-76248.3%−76224.5 pt vs Q1 2024
Net margin-70913.8%−70962.6 pt vs Q1 2024
ended Mar 31, 2025 · filed May 15, 2025 · 45 d after period end